ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
DAAs Cut Deaths in Those Treated for HCV-Related Liver Cancer
August 21, 2019Among patients with hepatitis C virus (HCV) infection and complete response to hepatocellular carcinoma (HCC) treatment, direct-acting antiviral (DAA) therapy is associated with a significant reduction in the risk for death... -
Cure Hepatitis C in 8 Weeks: Maviret, the Hepatitis C Drug with the Best Efficacy in the World, has Entered China
June 04, 2019The National Medical Products Administration of China (NMPA) has approved the marketing of AbbVie’s direct-acting antiviral (DAA) Maviret (glecaprevir/pibrentasvir) on May 15, 2019. -
Global HCV Drug Market Declined to below USD10 Billion in 2018, with only AbbVie’s Mavyret Outshining
March 11, 2019The global HCV drug market continued to shrink and reached USD7.767 billion in 2018.
Pharma Sources Insight January 2025
